Price movement over the last 24 hours
Align Technology, Inc. vs iShares Core MSCI Emerging Markets ETF — how do they compare? Align Technology, Inc. trades at $179.45 (market cap $12.86B), while iShares Core MSCI Emerging Markets ETF trades at $79.32. Which is the better fit depends on your goals.
| ALGN | IEMG | |
|---|---|---|
Market Cap | $12.86B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $207.19 | $86.00 |
52-Week Low | $124.88 | $59.90 |
Enterprise Value | $11.92B | — |
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
IEMG trades at $81.33, up 0.38% today, but technical indicators signal a bearish trend with moving averages and ADX pointing lower. The ETF has surged 35% over the past year, driven by strong inflows into emerging markets and a 40% technology weighting, particularly in South Korean and Taiwanese AI-related stocks. Recent news highlights record capital flows and outperformance versus developed markets, though volatility remains elevated.
Outlook is mixed: attractive valuations and AI exposure offer growth potential, but concentration risk and geopolitical tensions pose headwinds. Investors face trade-offs between higher returns and increased volatility, with analyst sentiment cautious due to recent price gains.
Trailing returns across standard periods
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →IEMG tracks the MSCI Emerging Markets Investable Market Index, providing broad exposure to large, mid, and small-cap stocks across over 20 emerging market countries. It is designed as a low-cost core holding for investors seeking diversified growth from economies outside of developed markets.
Read more on IEMG →